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Neural activity is intimately tied to blood flow in the brain. This coupling is specific enough in space and time
that modern imaging methods use local hemodynamics as a measure of brain activity. In this review, we
discuss recent evidence indicating that neuronal activity is coupled to local blood flow changes through
an intermediary, the astrocyte. We highlight unresolved issues regarding the role of astrocytes and propose
ways to address them using novel techniques. Our focus is on cellular level analysis in vivo, but we also relate
mechanistic insights gained from ex vivo experiments to native tissue. We also review some strategies to
harness advances in optical and genetic methods to study neurovascular coupling in the intact brain.Introduction
Normal brain activity depends on a continuous supply of oxygen
and glucose through cerebral blood flow (CBF). Although cere-
bral energetic demands are very high, the brain has very little
means of energy storage (Attwell and Laughlin, 2001). Therefore,
local brain activity has to be matched by a concomitant increase
in local CBF—a phenomenon referred to as functional hyperemia
or neurovascular coupling.
Understanding the mechanisms underlying functional hyper-
emia is important for several reasons. First, noninvasive func-
tional brain imaging methods, which have provided insight
into the human brain at work at unprecedented detail (Raichle,
1998), rely on this coupling—in particular, the greater rise in
CBF compared to oxygen consumption—to map brain activity
(Lauritzen and Gold, 2003; Logothetis, 2003; Raichle and Min-
tun, 2006; Villringer and Dirnagl, 1995). Therefore, the more
we know about the signaling pathways, the better we will under-
stand what kind of underlying brain activity these techniques
reflect. Second, perturbed functional hyperemia is involved
in the pathophysiology of several neurological diseases (dis-
cussed below) (Attwell et al., 2010; Girouard and Iadecola,
2006; Iadecola, 2004), and identifying key steps in functional
hyperemia may facilitate alleviation or treatment of these
disorders.
Recently, astrocytes have been proposed as important
conduits between neuronal and vascular activity. In this review,
we will discuss the role of astrocytes in functional hyperemia,
highlight the unresolved issues regarding astrocytes, and pro-
pose how they can be addressed by novel techniques. Our focus
is on analysis of cells in their native environment in vivo, but we
also discuss the role of molecular pathways gleaned from
ex vivo studies. For aspects of functional hyperemia not related
to astrocytes, and for astrocytic functions other than functional
hyperemia, we refer the reader to a number of excellent and
recent reviews (Barres, 2008; Halassa and Haydon, 2010;
Iadecola, 2004; Lauritzen, 2005; Sofroniew and Vinters, 2010;
Volterra and Meldolesi, 2005). We have taken the liberty of
combining information from different species and brain regions,
hoping to identify common principles.782 Neuron 71, September 8, 2011 ª2011 Elsevier Inc.A Macroscopic View of Cerebrovascular Regulation
Most of cerebrovascular regulation takesplaceon the arterial side
of the cerebral vasculature, which can be divided into large pial
arteries, derived from arteries branching off the circle of Willis,
penetrating arterioles delving into the tissue, and capillaries,
where most of the oxygen diffusion into the parenchyma occurs
(Figures 1A–1D). Local CBF changes are induced by constriction
or relaxation of smooth muscle cells in arteries and arterioles.
As penetrating arterioles are located within regions of synaptic
activity (Figure 1D) and, together with surface arteries, account
for a large part of cerebrovascular resistance (Faraci andHeistad,
1990), they are probably the main targets of local neuronal and
glial pathways regulating functional hyperemia. This functional
network of neurons, glia, and vascular cells has been termed the
neurovascular unit (Figure 1D). In addition, upstream dilation of
surface arteries and larger penetrating arterioles is also neces-
sary for adequate and sufficient downstream CBF increase (Erin-
jeri and Woolsey, 2002; Iadecola et al., 1997; Tian et al., 2010).
Since these larger upstream vessels are separated from neurons
and astrocytes by the Virchow-Robin space, it has been postu-
lated that intramural (Dietrichet al., 1996) or flow-mediatedsignals
(Fujii et al., 1991) convey intraparenchymal changes to these
surface vessels, although the glia limitans, a network of astrocytic
processes covering the brain’s surface, may also contribute to
neurovascular signaling (Xu et al., 2008). Finally, although capil-
laries lack smoothmuscle cells, they are surrounded by pericytes
(Figure 1D), which contribute to microvascular CBF (Bell et al.,
2010), and which may have the ability, at least in vitro, to actively
regulate capillary diameter (Kawamura et al., 2003; Peppiatt et al.,
2006), although their contribution to functional hyperemia in vivo
remains uncertain (Ferna´ndez-Klett et al., 2010).
In summary, signaling from neurons in activated brain regions
to local penetrating arterioles (and possibly also capillaries) and
a coordinated response of surface vessels, are necessary for
local CBF to increase during neuronal activation.
Neuronal Regulation of Local Blood Flow
Because brain research has traditionally been centered on
neurons, and neuronal activity can easily be measured by
Figure 1. Organization of the Cerebral Vasculature
(A) The architecture of cerebral vasculature exemplified by casts obtained from human brains. Note the penetrating vessels, from which capillaries emerge to
perfuse brain tissue. Cortical layers are indicated at the left along with cartoons of neuronal cell bodies.
(B) Tangential section through layer 4 from human brain showing the relatively homogeneous coverage of capillaries, except the regions immediately surrounding
arteries.
(C) Three-dimensional volume rendering of human vascular network reconstructed from India ink injected into blood vessels of human brain. Pial surface is on top
and the scale bar is 1 mm.
(D) Schematic of the various elements of the neurovascular unit. Penetrating arterioles and capillaries are completely covered by astrocytes. Interneurons
targeted at the vasculature synapse onto astrocytes. Astrocytes also detect synaptic activity at neuronal synapses.
Panels (A) and (B) are reproduced with permission from Duvernoy et al. (1981) and (C) from Lauwers et al. (2008).
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view that neuronal activity directly triggers functional hyperemia.
Neuronal processes are indeed closely associated with all parts
of the vasculature. Pial arteries and large surface arterioles are
innervated by nerve fibers that originate in autonomic and
trigeminal sensory ganglia (Hamel, 2006). In the brain paren-
chyma, penetrating arterioles and capillaries are contacted by
local interneurons (Figure 1D) as well as by processes of intrinsic
neurons originating from subcortical centers (Golanov et al.,
2001; Hamel, 2006; Rancillac et al., 2006; Yang et al., 2000). In
addition, centrifugal brainstem fibers may also indirectly affect
functional hyperemia by modulating glutamate release from ex-
citatory synapses (Petzold et al., 2009).
If neurons and blood vessels are closely associated anatomi-
cally, what signals are then responsible for the functional transfer
of information between the two? Early hypotheses focused on
the relation between neuronal metabolism and local circulation
and proposed that increased energy use and/or oxygen con-
sumption of neurons directly trigger vasodilation (Siesjo, 1978).
However, changes in hemodynamics can appear within 1–3 s
of increased neural activity, while metabolic changes occur
more slowly than this (Lou et al., 1987), indicating that the nature
of neuron-to-vessel signaling is more complex. In addition, neu-
rovascular coupling remains unchanged in the face of experi-mental variations of oxygen and glucose supply (Mintun et al.,
2001; Powers et al., 1996), and oxygen consumption occurs in
a much smaller area than the subsequent CBF increase (Attwell
and Iadecola, 2002; Malonek and Grinvald, 1996). These studies
indicated that blood flow changes occur through several inter-
mediate steps, rather than by direct activation through products
of cerebral energy metabolism. Indeed, later studies demon-
strated that a large fraction of functional hyperemia can be
attributed to actions of the excitatory neurotransmitter gluta-
mate (Lauritzen, 2005). For example, ionotropic glutamate
receptor activation may mediate functional hyperemia by
calcium-activated synthesis of nitric oxide (NO), prostaglandins,
and epoxyeicosatrienoic acids in neurons (Akgo¨ren et al., 1994;
Faraci and Breese, 1993; Lindauer et al., 1999; Niwa et al.,
2000a; Peng et al., 2002). In addition, the vasculature-targeted
information is conveyed by anatomically discrete local interneu-
rons (Figure 1D), which either can be activated locally by presyn-
aptically released glutamate, as in stellate neurons of the cere-
bellum (Rancillac et al., 2006; Yang et al., 2000), or can act as
relays for remote brainstem nuclei, such as the cholinergic basal
forebrain nucleus or the serotonergic raphe nuclei (Cauli et al.,
2004).
In sum, although there is a close relationship between oxygen
consumption and functional hyperemia (Hoge et al., 1999; LinNeuron 71, September 8, 2011 ª2011 Elsevier Inc. 783
Figure 2. Astrocytes Are Key Elements of Neurovascular Coupling
(A) GFAP stain (blue or cyan) highlights the larger processes of astrocytes, some of which envelop a small arteriole labeled with laminin (green). Also shown are
glutamatergic synapses, labeled with antibodies against vesicular glutamate transporter 1 (VGluT1; red).
(B) Electron micrograph from cerebellum showing Bergmann glia contacting blood vessel. In this image, the glial process is highlighted by photoconversion of
GFP, which is expressed only in a subset of Bergmann glia in this line of mice. Magnification of the boxed region clearly illustrates the close contact between
astrocytic processes and blood vessel.
(C) Astrocytes from the cortex of a ‘‘brainbow’’ mouse showing their tiling, and the private territory each occupies. Dark ovoid regions are mainly neuronal cell
bodies. In the right image, a small region is shown at higher magnification, revealing the boundaries between neighboring astrocytes.
(D) Serial sections show glial processes (dark regions with photoconverted GFP) in close proximity to a synapse.
Panels (A), (B), and (D) are courtesy of Dr. Akari Hagiwara (unpublished data). Panel (C) shows images courtesy of Dr. Jean Livet and based on published data
(Livet et al., 2007).
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not directly trigger blood flow changes. Instead, the same neu-
rotransmitters that mediate neuron-to-neuron information ex-
change also initiate polysynaptic signaling pathways that ulti-
mately trigger functional hyperemia.
Astrocytes Are Anatomical Intermediaries between
Neurons and Blood Vessels
The intraparenchymal vasculature is extensively covered by as-
trocytic endfeet (Mathiisen et al., 2010; McCaslin et al., 2011)
(Figure 2A and 2B), which may serve as functional intermediaries
between neurons and blood vessels. This intimate anatomical
relationship between astrocytes and blood vessels was already
noted in some of the earliest descriptions of astrocytic mor-
phology by Cajal and Golgi (Golgi, 1886; Ramon y Cajal, 1895).
Recent analyses of astrocytic morphology have revealed that
the vascular external surface is almost completely covered by
astrocytic endfeet (Mathiisen et al., 2010; Nielsen et al., 1997;
Petzold et al., 2008; Simard et al., 2003). Moreover, perivascular
astrocytic endfeet (Figure 2B) are important and highly special-
ized cellular compartments that are enriched in astrocyte-
specific proteins such as aquaporin-4, connexin 43, purinergic
receptors, and potassium channels (Price et al., 2002; Simard
et al., 2003). Finally, at the ultrastructural level, the processes
of many vasoactive interneurons, in particular those expressing
noradrenaline, synapse onto astrocytes rather than directly
onto blood vessels (Hamel, 2006).784 Neuron 71, September 8, 2011 ª2011 Elsevier Inc.These morphological and functional data indicate that, with
the possible exception of gaseous transmitters, all signaling
molecules targeted to the vasculature must first act on or pass
through astrocytes in order to reach the smooth muscle cells in
the vessel wall (Figure 1D). The organization of astrocytes into
separate domains (Halassa et al., 2007) (Figure 2C) and the
very close anatomical and functional relationship between astro-
cytes and neuronal synapses (Barres, 2008; Haydon, 2001)
(Figure 2D) make these cells ideal candidates to convey changes
in neuronal activity levels to the vasculature and to be common
executors of neurovascular pathways.
A Historical Perspective of Astrocytic Regulation
of Vascular Tone
The first recorded person to implicate astrocytes in functional
hyperemia was Ramo´n y Cajal, who hypothesized in 1895
that constriction of astrocytic endfeet would trigger vasocon-
striction and endfeet relaxation would induce vasodilation
(Garcı´a-Marı´n et al., 2007). About a century later, Paulson
and Newman proposed astrocytic potassium ‘‘siphoning’’—i.e.,
influx of potassium ions into astrocytes near active synapses,
and efflux of potassium from astrocytic endfeet into the peri-
vascular space and subsequent potassium-induced vaso-
dilation—as a mechanism of functional hyperemia (Paulson
and Newman, 1987). Moreover, Harder and colleagues noted
that astrocytes express all proteins necessary to detect neu-
ronal activity and, facilitated by astrocytic calcium elevations,
Neuron
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1998).
Since astrocytes, unlike neurons, are electrically inexcitable,
they are relatively inert to traditional electrophysiological meth-
ods. Therefore, studies of astrocytic activity were only possible
after the introduction of calcium dyes (Tsien, 1988) and their
delivery into identified astrocytes (Kang et al., 2005; Nimmerjahn
et al., 2004). Most data on astrocytic influences on CBF so far
have been obtained in acute brain slices, because they offer
excellent experimental control, are technically practical, and
allow relatively easymerging of imaging and electrophysiological
techniques (Figure 3A).
Cellular imaging of neurons and astrocytes together with CBF
recordings in single vessels in vivo in living animals was achieved
only relatively recently, using multiphoton microscopy of fluo-
rescently labeled blood vessels and multicell bolus loading of
calcium indicators (Helmchen and Kleinfeld, 2008; Kleinfeld
et al., 1998; Stosiek et al., 2003) (Figures 3B–3D). A particularly
valuable development has been the ability to monitor blood
flow in individual capillaries by following the movement of eryth-
rocytes (Chaigneau et al., 2003; Dirnagl et al., 1992; Kleinfeld
et al., 1998) (Figures 3B and 3D), enabling simultaneous re-
cording of CBF and cellular activity with high spatial and
temporal resolution.
Astrocytic Activation Changes Vascular Tone in Acute
Brain Slices
The different pathways involved in the vascular changes
following astrocytic activation in brain slices, which are, together
with findings obtained in vivo (discussed below), summarized in
Figure 4, have been extensively discussed in recent reviews (Att-
well et al., 2010; Iadecola and Nedergaard, 2007; Koehler et al.,
2009). Briefly, several brain slice studies showed that stimulation
of cortical astrocytes, either directly or through nearby neurons,
triggers an intraastrocytic calcium surge and a subsequent dila-
tion or constriction of neighboring arterioles. Vasodilation was
triggered by activation of astrocytic metabotropic glutamate
receptors (mGluR) and either cyclooxygenase products (Filosa
et al., 2004; Zonta et al., 2003) or combined activation of different
potassium channels on astrocytes and smooth muscle cells
(Filosa et al., 2006). Vasoconstriction, in turn, was mediated by
the conversion of astrocytic arachidonic acid derivates to 20-
hydroxyeicosatetraenoic acid (20-HETE) in smooth muscle cells
by the cytochrome P450 system (Mulligan and MacVicar, 2004).
In other studies, vasoconstriction and vasodilation were both
observed, depending on the level of nitric oxide (Metea andNew-
man, 2006) or oxygen in the tissue (Gordon et al., 2008). Finally,
the level of the astrocytic calcium elevation itself has been sug-
gested to determine the polarity of the arteriolar response (Giro-
uard et al., 2010).
Studying vascular regulation in slices has significant advan-
tages, including the exquisite control over cellular elements.
However, an inherent and critical limitation of studies in brain sli-
ces is that blood vessels in these preparations lack perfusion
and, therefore, are maximally dilated, because myogenic tone
induced by intraluminal pressure is missing (Iadecola and Neder-
gaard, 2007). In most studies, slices were pretreated with vaso-
constrictive agents to compensate for the loss in tone (Filosaet al., 2004, 2006; Metea and Newman, 2006; Zonta et al.,
2003). Preconstriction of vessels in slices, as well as large
changes in the oxygen tension, can result in the conversion of
arteriolar constriction into dilation (Gordon et al., 2008; Mulligan
and MacVicar, 2004). This conversion has been suggested to
underlie competing roles of astrocytes during different states
of brain activation, but it is difficult to decide what is more phys-
iological or at least less artificial—preconstriction of vessels by
pharmacologically blocking the production of important sig-
naling molecules such as NO (Zonta et al., 2003), leaving vessels
untreated and, thus, maximally dilated (Mulligan and MacVicar,
2004) (Figure 3A), or inducing variations of tissue oxygen tension
(Gordon et al., 2008) that are larger than those measured in the
intact brain during physiological activation (Ances et al., 2001;
Offenhauser et al., 2005). Another important point to consider
is how slice stimulation protocols relate to typical physiological
sensory stimulation (Anderson and Nedergaard, 2003). It is also
difficult to speculate whether the very slow time scale at which
vessel tone changed in some studies (Gordon et al., 2008; Zonta
et al., 2003) (Figure 3A) is an effect of slice temperature, maxi-
mally dilated vessels, or lack of perfusion.
In the following paragraphs, we will discuss how astrocytes
might mediate functional hyperemia in vivo (also summarized
in Figure 4). As outlined below, there are several open questions
regarding how astrocytes are activated by glutamate, how
quickly and by what pathways they respond, and by what mech-
anisms they might ultimately regulate functional hyperemia.
How and at What Time Scale Do Astrocytes Respond
to Synaptic Activity in Vivo?
Takano et al. (2006) were the first to show that astrocytic calcium
elevations induce vasodilation of cortical penetrating arterioles
(Figure 5A). However, whether the time course of sensory-
evoked astrocytic calcium changes is actually compatible with
the onset and temporal sequence of functional hyperemia has
remained an open question. Following initial demonstrations of
spontaneous calcium dynamics in astrocytes in the intact brain
(Hirase et al., 2004; Nimmerjahn et al., 2004), it was shown that
sensory stimulation of whiskers (Wang et al., 2006) or direct
cortical electrical stimulation (Takano et al., 2006) elicited
calcium transients in layer II astrocytes in mouse somatosensory
cortex. Astrocytic responses peaked at stimulation frequencies
at which local synaptic input was highest (measured by summed
local field potential) and were much smaller at weaker synaptic
activation (Wang et al., 2006). The latency of onset of these
calcium changes was in the order of 1–6 s—i.e., later than the
onset of functional hyperemia, which typically occurs at about
1 s after stimulus onset (Tian et al., 2010). In another study in
ferret visual cortex, astrocytes responded at a delay of 3–4 s (Fig-
ure 5B), and, similar to somatosensory cortex, were sharply
tuned to maximal synaptic input (Schummers et al., 2008). In
olfactory glomeruli, astrocytic calcium elevations in response
to odor stimulation commenced about 1–2 s after stimulus onset
(Petzold et al., 2008), although the precise stimulus onset is more
difficult to determine here because of variations in the flow of
odorants to the nose as well as breathing and sniffing rates of
the animals. In the cortex, a subset of astrocytes showed
rapid responses more compatible with the onset of functionalNeuron 71, September 8, 2011 ª2011 Elsevier Inc. 785
Figure 3. Cellular-Level Measurements of the Elements in Neurovascular Coupling
(A) Vessel diameter can be directly measured with calcium dynamics in ex vivo preparations, such as the acute brain slice preparation. Upper panel: calcium
uncaging in astrocytes (labeled with the calcium indicator Rhod-2) is associated with subsequent arteriolar vasoconstriction (scale bar, 20 mm). Lower panel:
afferent electrical stimulation induces arteriolar vasodilation (scale bars, 10 mm). Down and up triangles in the graph indicate the duration of stimulation. Note the
relatively slow kinetics of the vessel response compared to in vivo conditions.
(B) Blood flow can be measured in vivo by high-speed imaging of red blood cell (RBC) movement in capillaries using multiphoton microscopy. In this example,
fluorescent dyes in the plasma allow erythrocytes to be seen as dark shadows. By performing rapid line scans along the capillary axis, passing RBCs appear as
dark bands in the fluorescent plasma. CBF parameters can then be calculated from these bands (the time between two bands, Dt, is inversely proportional to
786 Neuron 71, September 8, 2011 ª2011 Elsevier Inc.
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Figure 4. Postulated Signaling Pathways from
Synapse to Blood Vessel
Molecular pathways that have been identified in in vivo
and in vitro studies are displayed. Pathways that have only
been identified in vitro, but await characterization in vivo,
have been highlighted to the right. Question marks indi-
cate unknown molecular mediators. In summary, pre-
synaptic terminals release glutamate (Glu), which acts on
postsynaptic neurons and astrocytes. In postsynaptic
neurons, glutamate activates ionotropic receptors (iGluR),
which trigger calcium elevations that activate neuronal NO
synthase (nNOS) and cyclooxygenase 2 (COX2), which in
turn leads to production of PGE2. It is not known whether
PGE2 dilates blood vessels by acting on smooth muscle
cells or on astrocytes. In astrocytes, glutamate activates
metabotropic glutamate receptors-5 (mGluR5), which
triggers calcium elevations that—by phospholipase A2
(PLA2)-mediated synthesis of arachidonic acid (AA)—lead
to production of PGE2 through COX1 and epoxyeicosa-
trienoic acids (EETs) through cytochrome P450 2C11 ep-
oxygenase (CYP2C11). Moreover, calcium induces po-
tassium release from astrocytic endfeet through large
conductance calcium-dependent potassium channels
(BKCa), which in turn triggers vasodilation through hyper-
polarization of smooth muscle cells via inward-rectifier
potassium channels (Kir). Glutamate is also taken up into
astrocytes through glutamate/Na+-cotransport, but the
pathways that eventually lead to vasodilation remain
unknown. In addition to these neurovascular pathways,
endothelial cells can also trigger vasodilation via endo-
thelial NO synthase (eNOS) and PGIi production by COX1.
Slice studies have suggested that astrocytic calcium can
by unknown mechanisms also lead to vasoconstriction
through the production of 20-hydroxyeicosatetraenoic acid (20-HETE) mediated by cytochrome P450 4A (CYP4A) u-hydroxylase. In slices, low [O2] may inhibit
vasoconstriction through increased production of lactate (which may inhibit astrocytic PGE2 reuptake) and adenosine.
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et al., 2007). Another study found astrocytic calcium elevations in
somatosensory cortex in awake mice, which appeared 1–2 s
after the onset of voluntary running (Dombeck et al., 2007). How-
ever, in both studies, but in contrast to other studies (Schum-
mers et al., 2008) (Figure 5B), the onset and kinetics of calcium
responses in neurons and neuropil, which were simultaneously
labeled with the same calcium indicator, were similar to the as-
trocytic response (Dombeck et al., 2007; Winship et al., 2007),
indicating that they might have been included in the axial depth
of the optical plane and may have contributed to the imaging
signal. In yet another study in awake behaving mice, the onset
of calcium ‘‘flares,’’ which were abundant in awake mice but
absent in anesthetized animals, in cerebellar Bergmann glia,
closely matched the onset of functional hyperemia (Nimmerjahn
et al., 2009) (Figure 5C). However, CBF was measured in sepa-
rate animals by laser-Doppler flowmetry in a much larger tissue
volume than the calcium measurements, making it difficult toRBC flux; the distance between bands, Dx, is inversely proportional to RBC linea
velocity).
(C) Calcium signals in neurons and astrocytes can be imaged using multiphoton m
101 (SR101). In this example from Nimmerjahn et al. (2004), astrocytes are visu
Spontaneous calcium responses were measured in both cell types, and had sign
also be imaged under various conditions.
(D) In the olfactory bulb, several different cellular elements can be imaged simulta
estimated by fluorescence imaging, of nerve terminals expressing synaptopHlu
using calcium imaging, and blood flow by measuring erythrocyte velocity.
The following images are reproduced with permission: (A) from Mulligan and Mac
and Kleinfeld (2008), (C) from Nimmerjahn et al. (2004), and (D) from Petzold et aaccurately relate the onset of functional hyperemia with astro-
cytic calcium. In summary, calcium elevations in different sys-
tems and after different stimulation paradigms typically occur
in areas of maximal synaptic activity and often start somewhat
later than functional hyperemia.
Given that astrocytic responses in vivo are typically detected
after the onset of functional hyperemia, how can they be respon-
sible for the vascular changes? One can envision three possible
scenarios. First, calcium elevations in astrocytes in all of these
studies were monitored using synthetic dyes, loaded into cells
using the membrane permeant AM ester form, and by identifying
astrocytes using either genetic markers (Zhuo et al., 1997) or sul-
forhodamine 101 (Nimmerjahn et al., 2004). However, the dye is
taken up by all cells, and even when using counterstains (Figures
3C and 5C), signal separation can become difficult (Go¨bel and
Helmchen, 2007; Grewe and Helmchen, 2009). In addition, the
time course of calcium responses in neurons and astrocytes is
influenced by the properties of the indicator as well as ther density; and the slope of the bands, Dt/Dx, is inversely proportional to RBC
icroscopy and selective labeling of astrocytes using the dye sulforhodamine-
alized as yellow regions (overlap of red SR101 and green calcium indicator).
ificantly different temporal dynamics. Evoked responses in both cell types can
neously or separately under very similar conditions. Presynaptic activity can be
orin (spH), postsynaptic and astrocytic activity (identified by GFP expression)
Vicar (2004) (upper row) and Zonta et al. (2003) (lower row), (B) from Helmchen
l. (2008).
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Figure 5. Relation between Astrocyte Activity and
Blood Flow
(A) Increasing calcium concentration in astrocytic endfeet
surrounding a blood vessel causes vasodilation. In this
example, calcium increases were induced by uncaging,
and measurements of calcium levels and vessel diameter
done using multiphoton microscopy (in the line scan
mode). Calciumwas measured using Rhod-2, and vessels
were visualized using a dextran-coupled dye. Although the
overall time course is gradual, the vessel diameter tracks
the rise in calcium concentration in the endfoot.
(B) Astrocytic responses following sensory stimulation
occur several seconds after the stimulus and have a time
course distinct from neuronal responses. Images show
astrocytes and neurons in ferret visual cortex labeled with
the calcium indicator Oregon Green BAPTA-1 (OGB1,
green). The astrocyte was identified by costaining with
sulforhodamine 101 (SR101, purple). Lower image: time
course of neuronal (blue) and astrocytic (red) calcium
responses to visual stimulation (the thick bar represents
stimulation time). Scale bar, 25 mm.
(C) Calcium waves can occur in astrocytes vivo. In this
example, radially expanding calciumwaves, termed ‘‘Ca2+
bursts,’’ were measured using OGB1 in cerebellar Berg-
mann glia in awakemice. Fifteen frames are illustrated (five
time points and three different depths). The time courses
of these calcium signals are shown in the middle panel
(black, individual traces; green, mean time course). In the
bottom panel, the time course of large-scale concerted glial calcium signals, termed ‘‘Ca2+ flares,’’ is shown (black) along with average blood flow changes
(green), both averaged by triggering on movement onset (vertical line; note, however, that these measurements were taken in separate groups). Two different
types of movement were considered: brief movement and extended movements. The onset of blood flow changes tracks glial calcium well for both cases.
However, for extended movements, blood flow stays high even though glial calcium levels return to baseline.
The following images are reproduced with permission: (A) from Takano et al. (2006), (B) from Schummers et al. (2008), and (C) from Nimmerjahn et al. (2009).
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Neher and Augustine, 1992), although onset kinetics are prob-
ably not affected significantly.
A second scenario is that calcium changes in astrocytes do
occur earlier than functional hyperemia but that they are not
picked up by the indicator. This may be either because the
affinity of typical bulk-loaded indicators is too low to detect
very subtle calcium changes or because the indicators tend to
accumulate in somata and larger processes, leaving out the
extensive network of smaller astrocytic processes and their
even finer ramifications. There is clear evidence for differences
in calcium signals recorded in astrocyte somata and fine pro-
cesses (Reeves et al., 2011). Perhaps progress can be made if
astrocytes can be selectively labeled with calcium indicators,
especially with genetically encoded indicators such as GCaMPs
(Nakai et al., 2001; Shigetomi et al., 2010; Tian et al., 2009),
troponin-based probes (Mank et al., 2006, 2008), and chame-
leons (Atkin et al., 2009; Miyawaki et al., 1997; Truong et al.,
2007).
A third scenario is that calcium changes in astrocytes indeed
appear later than functional hyperemia. For example, it is
possible that nonastrocytic mechanisms—e.g., neuronal NO or
dedicated interneurons—trigger the initial rise of functional
hyperemia, but that astrocytic pathways are necessary to main-
tain the response. Moreover, signaling steps between astrocytic
activation and calcium increase, such as diacylglycerol produc-
tion, may also be vasoactive. It is also feasible that calcium
represents just one of many different vasoactive astrocytic
messengers, such as sodium (Bernardinelli et al., 2004), protons
(Amato et al., 1994; Chesler and Kraig, 1987), cAMP (Moldrich
et al., 2002), ATP (Cotrina et al., 2000; Pascual et al., 2005), or788 Neuron 71, September 8, 2011 ª2011 Elsevier Inc.lactate (Gordon et al., 2008). Future experiments may benefit
from monitoring changes in these parameters within astrocytes
in vivo.
In addition to monitoring calcium rises, it is also important to
be able to perturb calcium levels within astrocytes at will. One
method that has been used successfully is optical uncaging—
caged calcium loaded into astrocytes can be released by ultra-
violet light, a method that has been used extensively in vitro
(Filosa et al., 2006; Gordon et al., 2008; Metea and Newman,
2006; Zonta et al., 2003) (Figure 3A). In vivo uncaging was shown
to lead to vessel dilation (Takano et al., 2006) (Figure 5A), but
additional experiments with more controlled and spatially
confined changes in calciummay offer more refined information.
How Are Astrocytes Activated by Neuronal Activity?
Neuron-derived substances, such as glutamate, GABA, nor-
adrenaline, acetylcholine, dopamine, ATP, and nitric oxide,
trigger propagating astrocytic calcium elevations in culture (Hay-
don andCarmignoto, 2006; Volterra andMeldolesi, 2005). So far,
only glutamate has been shown to be relevant for astrocytic acti-
vation following sensory stimulation in vivo. In cortex, local inhi-
bition of the metabotropic glutamate receptors mGluR1 and
mGluR5, respectively, decreased astrocytic calcium elevations
evoked by whisker stimulation by about 40%–50% each
(Wang et al., 2006). Similarly, in olfactory glomeruli, inhibition of
mGluR5 decreased the rise of astrocytic calcium (as well as
functional hyperemia) following odor stimulation (Petzold et al.,
2008). Neither presynaptic (Petzold et al., 2008) nor postsynaptic
neuronal activity (Wang et al., 2006) was altered by the pharma-
cological treatment, indicating that the effect was mainly attrib-
utable to astrocytic but not neuronal mGluRs. As an additional
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by the glutamate/sodium cotransporter decreased functional
hyperemia in the mouse olfactory bulb (Petzold et al., 2008)
and in the ferret visual cortex (Schummers et al., 2008).
As in any complex signaling system, many uncertainties
remain. For example, some studies have suggested that mGluR5
might be predominantly expressed in neurons in the mature
brain (Barres, 2008; D’Antoni et al., 2008). Moreover, pharmaco-
logical blockade of glutamate uptake increases the concentra-
tion and half-life of glutamate at the synaptic space, although
the effect of astrocytic glutamate transport inhibition on func-
tional hyperemia remained in the olfactory bulb when all neuronal
targets of glutamate as well as astrocytic mGluRs were blocked
(Petzold et al., 2008). It is currently unclear to what extent gluta-
mate uptake-mediated functional hyperemia depends on a rise
in astrocytic calcium. Astrocytic calcium responses remained
unaltered after relatively specific blockade of astrocytic trans-
porters in the olfactory bulb (Petzold et al., 2008). In contrast,
injections of high concentrations of the unspecific neuronal
and astrocytic uptake inhibitor TBOA decreased astrocytic
calcium elevations in ferret visual cortex (Schummers et al.,
2008). The mechanisms responsible for this decrease remain
to be determined, especially since neuronal calcium responses
increased simultaneously because TBOA elevated synaptic
glutamate and this should theoretically increase astrocytic
calcium. Additional nonpharmacological studies will be neces-
sary to clearly delineate the role of astrocytic glutamate uptake
and mGluRs for functional hyperemia. This could be achieved
by using genetically engineered mice in which metabotropic
receptor pathways are knocked in or out specifically in astro-
cytes (Fiacco et al., 2007; Petravicz et al., 2008). Better temporal
and spatial resolution may be achieved by the use of optically
activated G protein-coupled receptors, referred to as OptoXRs
(Airan et al., 2009). These chimeric receptors have opsin
domains that can be activated by light, and intracellular
domains—e.g., the signaling domain of mGluR5—that allow
them to signal like native receptors. In addition, specific manip-
ulation of neurons using optogenetic probes such as channelr-
hodopsins (Boyden et al., 2005; Miesenbo¨ck, 2009; Nagel
et al., 2003) could reveal the role of pre- and postsynaptic activa-
tion (see below), and the contribution of specific interneurons.
Astrocytes could also be activated directly, bypassing neurons,
using channelrhodopsins (Gourine et al., 2010; Gradinaru et al.,
2009). It remains to be established, however, that activation of
channelrhodopsin-2 (ChR2) in astrocytes can cause significant
depolarization (because of the low electrical impedance) and
that these depolarizations have a signaling role. Finally, to test
the roles of glutamate transporters, gene-targeted mice lacking
specific transporters in astrocytes can be used (Colin et al.,
2009).
What Is the Role of Postsynaptic Activity for Astrocyte-
Mediated Functional Hyperemia?
All astrocytic pathways identified so far require the direct action
of glutamate on astrocytes (Petzold et al., 2008; Schummers
et al., 2008; Takano et al., 2006; Wang et al., 2006). In contrast,
when the activity of postsynaptic neuronal NMDA and AMPA
receptors was blocked locally, no changes were seen in func-tional hyperemia (Chaigneau et al., 2007; Petzold et al., 2008)
or intrinsic optical signals (Gurden et al., 2006) in the olfactory
bulb. Moreover, no effect on astrocytic calcium transients
evoked by sensory stimulation was observed in somatosensory
cortex in vivo after blockade of postsynaptic NMDA and AMPA
receptors (Wang et al., 2006).
These results indicate that astrocytesmainly detect presynap-
tically released glutamate, and that local postsynaptic neuronal
activity plays only a minor role in the vasoactive actions of
astrocytes. Accordingly, presynaptic activity, when measured
simultaneously with CBF using a fluorescent marker for gluta-
mate release, correlates strongly with functional hyperemia in
olfactory glomeruli (Petzold et al., 2008) (Figure 3D). In contrast,
earlier studies have shown that postsynaptic neuronal activity
triggered by ionotropic glutamate receptor activation repre-
sents an important pathway in functional hyperemia in the
neocortex and cerebellum (Gsell et al., 2006; Lauritzen, 2005;
Yang and Iadecola, 1996). In addition, recent studies may indi-
cate that the neuronal stimulus strength might influence which
mechanism—presynaptic/astrocytic activity or postsynaptic/
neuronal activation—prevails in the control of functional hyper-
emia. While sparse activation of single glomeruli in the olfactory
bulb using low odorant concentrations revealed a contribution
of presynaptic glutamate release and astrocytic activity to the
local glomerular CBF response (Petzold et al., 2008), another
study reported that clustered activation of many glomeruli, i.e.
a stronger and more widespread stimulus, triggered CBF re-
sponses that were attenuated by global, but not local, postsyn-
aptic blockade (Chaigneau et al., 2007).
It is possible that the contribution of presynaptic activity may
have been underestimated in studies focusing on postsynaptic
activity because of the lack of direct markers of presynaptic
release in these systems, and because classical electrophysio-
logical indicators such as the local field potential mainly report
postsynaptic activity (Aroniadou-Anderjaska et al., 1997). More-
over, topical application of postsynaptic blockers will not only
decrease the activity of principal neurons, but also presynaptic
glutamate release from local excitatory neurons, which are nor-
mally recruited by recurrent activity. Notably, thalamocortical
synapses contribute to only a small fraction of the total number
of excitatory synapses in many sensory cortical areas (Douglas
and Martin, 2007; Peters and Payne, 1993; White, 1989). There-
fore, an experimental perturbation of postsynaptic activity will
probably also alter presynaptic release, which is usually very
difficult to measure concomitantly.
Overall, the results available today indicate that postsynaptic
neuronal activity may predominate in the control of CBF when
stimulation intensity is high or if widespread activation or co-
activation of distant areas occur, while presynaptic/astrocytic
activity may predominantly regulate CBF during mild or local
sensory stimulation. Such a shift may be optimal for matching
the CBF response to metabolic needs—for example, a quantita-
tive analysis of glomerular metabolic demands in the olfactory
glomerulus (Nawroth et al., 2007) showed that postsynaptic
receptor activation contributes to less than 0.3% of the total
energy budget during low activation but increases exponentially
to one-third with stronger activation patterns comparable to
those used by Chaigneau et al. (2007). In future studies, theseNeuron 71, September 8, 2011 ª2011 Elsevier Inc. 789
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harnessing optogenetics to express light-activated proteins in
neurons, allowing the experimenter to excite neurons more
specifically than feasible with physiological stimuli. Such exoge-
nous activation of neurons with spatiotemporal precision could
yield answers to questions such as: (1) how much activity is
necessary to cause hemodynamic changes, (2) how local (non-
local) is the hemodynamic change when neuronal activity is
focused to a small volume, (3) is postsynaptic activity dispens-
able for neurovascular coupling—this can be addressed by ex-
pressing optical inhibitors (Han and Boyden, 2007; Zhang
et al., 2007) in postsynaptic neurons. In structures such as the
olfactory bulb with clear morphological boundaries (such as
the glomeruli), optical stimulation of individual elements using
light can be used to great advantage (Dhawale et al., 2010).
Recent studies have demonstrated the feasibility of using opto-
genetic activation to study the origins of vasoactive signals
(Desai et al., 2011; Lee et al., 2010).
What Intraastrocytic Pathways Are Involved?
Although many questions regarding the activation of astrocytes
by glutamate remain unanswered, the picture is clearer for the
effects downstreamofmGluR5 activation. Photolysis of ‘‘caged’’
calcium in perivascular astrocytic endfeet triggered vasodilation
of cortical penetrating arterioles in anesthetized mice (Takano
et al., 2006) (Figure 5A). This dilation was strongly reduced by
inhibition of cyclooxygenase-1 (COX-1), which is expressed in
perivascular astrocytes (Takano et al., 2006) and microglia (Ca-
pone et al., 2010), resulting in the synthesis of vasoactive pros-
taglandins (Koehler et al., 2009), but not by inhibition of COX-2
(Takano et al., 2006), which is expressed in neurons (Wang
et al., 2005). Similarly, in olfactory glomeruli, COX-1 is expressed
by glomerular astrocytes, and its inhibition reduced functional
hyperemia, probably downstream of mGluR5 activation (Petzold
et al., 2008). A strong reduction in functional hyperemia was
recently found in human subjects carrying a COX-1 genotype
that results in lower enzymatic function (Hahn et al., 2011). In
contrast, a role for COX-2 in neurovascular coupling was sup-
ported by studies in somatosensory cortex (Niwa et al., 2000a;
Stefanovic et al., 2006), and functional hyperemia was not atten-
uated in COX-1 null mice (Niwa et al., 2001a). It is currently
unclear whether glial COX-1 and neuronal COX-2 may be acti-
vated at different kinetics, in different regions, or following
different stimulus paradigms. Moreover, the selectivity of some
COX inhibitors is lower in vivo than in vitro (Brenneis et al.,
2006), and some COX inhibitors have additional pharmacolog-
ical effects (Niwa et al., 2001a). To make matters even more
complicated, COX-2 and also COX-3 might also be expressed
in astrocytes under some conditions (Hirst et al., 1999; Kis
et al., 2003), and the expression profile of prostaglandin recep-
tors remains to be characterized in full detail (Andreasson,
2010). Finally, the effect of COX inhibition is regionally heteroge-
neous (Dahlgren et al., 1984; Niwa et al., 2001a), and the effect of
mGluR5 inhibition differs profoundly between different brain
regions (Sloan et al., 2010), indicating that some pathways might
prevail over others depending on the location, and that lessons
learned in one region may not be applicable elsewhere. Interest-
ingly, regional diversity has also been observed for the role of790 Neuron 71, September 8, 2011 ª2011 Elsevier Inc.nitric oxide in cortex (Lindauer et al., 1999) versus cerebellum
(Akgo¨ren et al., 1996; Yang et al., 2000).
The vasoactive pathways downstream of glutamate uptake
into astrocytes are largely unknown, but there are several in-
triguing possibilities. First, the cotransport of sodium and gluta-
mate slightly depolarizes the astrocyte, which could lead to
potassium efflux at astrocytic end-feet and subsequent vasodi-
lation (Filosa et al., 2006; Howarth and Attwell, 2006; Paulson
and Newman, 1987). However, the current generated by gluta-
mate transport is small compared to that generated by astrocytic
K+ uptake at the synaptic cleft in olfactory glomeruli (De Saint Jan
andWestbrook, 2005), and it seems unlikely that the blockade of
a comparatively small current would reduce functional hyper-
emia as much as observed. Second, CBF may increase as a
result of metabolic activation induced by glutamate uptake.
Sodium/glutamate cotransport consumes energy for the resto-
ration of the ionic gradient by the Na+-/K+-ATPase, and for the
conversion of glutamate to glutamine. While the contribution of
these processes to the brain’s energy budget is small (Attwell
and Laughlin, 2001), glutamate uptake into astrocytes also
directly initiates astrocytic nonoxidative glycolysis and lactate
release (Pellerin, 2005). Lactate itself may initiate vasodilation
(Gordon et al., 2008), but it is also possible that sodium ions co-
transported into astrocytes with glutamatemay trigger a vasoac-
tive pathway. Sodium ions shuttled into astrocytes by this
cotransport propagate as interastrocytic sodium waves in cell
cultures (Bernardinelli et al., 2004), and they have also been
shown to couple synaptic activity and astrocytic nonoxidative
glucose consumption (Voutsinos-Porche et al., 2003). This stim-
ulation of nonoxidative glycolysis in astrocytes is thought to
underlie the disproportionate rise of CBF and glucose compared
to a smaller increase in oxygen consumption—themismatch that
forms the basis of functional brain imaging (Magistretti and Pel-
lerin, 1999). Therefore, glutamate transport into astrocytes may
simultaneously activate functional hyperemia and nonoxidative
glycolysis in astrocytes, andmay contribute to the high temporal
and spatial correlation of CBF increase and glucose consump-
tion observed in functional brain imaging (Raichle and Mintun,
2006).
Advances in imaging and cellular manipulation may be
harnessed to overcome the uncertainties regarding the role of
astrocytic molecular agents in functional hyperemia. Optical
imaging during physiological activity can, in principle, be ex-
tended to any small molecule for which there is an appropriate
fluorescent indicator (Zhang et al., 2002). Genetic manipulations
may also be valuable, particularly if the perturbations can be
performed in a cell-type-specific and temporally precise manner
(Kennedy et al., 2010). Methods to stimulate or downregulate the
expression of genes, such as those for glutamate transporters,
specifically in mature astrocytes are increasingly becoming
available (Colin et al., 2009). Pharmacological methods with in-
creased specificity may also be useful, as will methods that
marry chemical approaches with genetic methods (‘‘chemical
genetics’’) (Knight and Shokat, 2005). For example, mutations
in transporters that confer susceptibility to blockade by exoge-
nous small molecules that have no effects on native proteins
could allow acute and reversible inhibition of transporters in
astrocytes.
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in Relation to Functional Hyperemia?
It is worth considering some of the physical and chemical
constraints for functional hyperemia. First and foremost, since
neurovascular coupling is spatially confined, the molecular
signals need to be generated and communicated locally. There-
fore, it is important to determine the range of integration and
range of influence of astrocytes, especially since astrocytes
are extensively coupled through gap junctions (Haydon, 2001).
Second, even if the vasoactive signals are generated locally,
they may spread far if they diffuse rapidly and have a long
lifetime—these parameters need to be measured for molecules
such as NO and ions such as potassium. Third, affecting blood
vessels in one placemay affect the perfusion nonlocally because
of vascular connectivity and passive redistribution of blood
(Boas et al., 2008). These considerations have been recognized
for some time but are not always attended to in molecular and
cellular studies. Finally, the same messenger might have dif-
ferent or even opposing effects on blood flow (Attwell et al.,
2010).
Another open issue is related to the spatial ‘‘reach’’ of astro-
cytes. Cortical astrocytes are organized into nonoverlapping
functional domains (Halassa et al., 2007) (Figure 2C). On the input
side, a single cortical astrocyte can, in principle, listen to tens of
thousands of synapses by virtue of its extensive processes
(Haydon, 2001), but it is unclear howmany synapses are needed
to activate an astrocyte. Recent in vivo experiments in visual
cortex indicate that astrocytes respond to visual stimulation
with calcium rises with exquisite selectivity, suggesting that their
‘‘input’’ field may be highly selective (Schummers et al., 2008).
Selective astrocytic responses were also found in slice experi-
ments in barrel cortex (Schipke et al., 2008). On the other
hand, what is the spatial extent of a single astrocyte’s output?
In theory, the organization of astrocytes into separate domains
may contribute to the spatial distribution of the CBF response
(Iadecola and Nedergaard, 2007). However, the input and output
selectivity may not be limited by the spatial extent of a single
astrocyte’s processes, since extensive gap junction coupling
of astrocytes may extend the range substantially by allowing
intercellular transfer of signaling molecules (Haydon, 2001;
Scemes and Giaume, 2006). The degree of astrocyte coupling
may also be regulated to make network topology modifiable.
The extent of astrocyte coupling in vivo is unclear. One
signaling event that has been observed to propagate across
astrocytes is a rise in calcium concentration. Calcium waves
spreading across multiple astrocytes were imaged more than
two decades ago in vitro (Cornell-Bell et al., 1990), but their
occurrence in vivo in themature brain under physiological condi-
tions has remained in question (Wang and Bordey, 2008).
Recently, spontaneous andmovement-evoked nonsynchronous
events (Nimmerjahn et al., 2009) and large coherent transglial
calcium waves (Hoogland et al., 2009; Nimmerjahn et al., 2009)
were observed in the cerebellum, as well as in cortex (Dombeck
et al., 2007). Whether these are all truly glial signals and whether
similar transglial calcium waves occur in other brain regions
awaits experimental testing. The existing data, however, suggest
that glial coupling is not an all-or-none phenomenon, but that it is
highly regulated. Of particular interest, Nimmerjahn et al. (2009)found that hemodynamic changes elicited in the cerebellum by
motor activity were accompanied by calcium rises in a large
number of Bergmann glia (Figure 5C), although the two signals
were measured in separate groups (see above). Whether such
large-scale coordinated signaling is required for local hemody-
namic changes is not clear, but is an important question for
future work. Interestingly, it was recently reported that neuronal
activity differentially modulated the level of coupling of astrocyte
networks in the olfactory bulb (Roux and Giaume, 2009), indi-
cating that the strength and range of astrocytic communication
might depend on the ongoing local neuronal activity.
What Is the Influence of the Behavioral State
on Astrocytes and Functional Hyperemia?
An important consideration for future experiments is the behav-
ioral state of the animal. For technical reasons, much of the work
to date has been conducted in anesthetized animals, where
movement is minimized and stimuli can be controlled well.
However, anesthetics by their very nature interfere with neuronal
signaling, and it is well known that they also affect functional
hyperemia (Lindauer et al., 1993, Nakao et al., 2001), although
the extent of which remains to be defined (Franceschini et al.,
2010). Therefore, the question arises whether astrocytic sig-
naling is also altered by the anesthetic state. A pioneering study
by Dombeck et al. (2007) examining calcium responses in the
somatosensory cortex of awake, mobile mice noted that astro-
cyte responses can be coordinated or independent of each
other, suggesting specific and variable coupling in astrocyte
networks. Recently, Nimmerjahn et al. (2009) found that calcium
signals in Bergmann glia in the cerebellar molecular layer had
different characteristics in different behavioral states as well as
different sensitivity to anesthetics. In the visual cortex, stim-
ulus-evoked astrocytic calcium signals and intrinsic optical sig-
nals, which reflect hemodynamics, were reduced by increasing
concentration of the volatile anesthetic isoflurane (Schummers
et al., 2008). An important direction for future research is the
examination of the cellular basis of neurovascular coupling in
different waking states—constrained, behaving, and startled—
with a particular emphasis on simultaneous imaging of neuronal,
astrocytic, and vascular network activity.
Pathophysiological Implications
Neurovascular coupling has been implicated in the pathogenesis
of several important neurological diseases. Functional hyper-
emia is attenuated after experimental and clinical focal ischemia,
(Girouard and Iadecola, 2006). It is currently unclear whether this
reduction represents a decoupling of functional hyperemia by
impaired cerebrovascular reactivity (Kim et al., 2005; Rossini
et al., 2004), or whether neurovascular coupling is preserved,
but has a reduced amplitude because the underlying neuronal
activity is attenuated (Bundo et al., 2002; Weber et al., 2008;
Zhang and Murphy, 2007). Moreover, ischemia also reduces
the ability of endothelial cells to initiate vasodilation (Kunz et al.,
2007). Functional hyperemia is also reduced following global
cerebral hypoxia (Schmitz et al., 1998), and in arterial hyperten-
sion (Girouard and Iadecola, 2006). In addition, pericyte-medi-
ated contraction of capillaries may also contribute to the pertur-
bation of blood flow after cerebral ischemia (Yemisci et al., 2009).Neuron 71, September 8, 2011 ª2011 Elsevier Inc. 791
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injury, and subarachnoid hemorrhage, spreading waves of neu-
ronal depolarization occur (Lauritzen et al., 2011). In the healthy
brain and during migraine aura, these events are associated with
a transient increase in local CBF (Hadjikhani et al., 2001; Laurit-
zen, 1987), and do not induce overt neuronal injury (Nedergaard
and Hansen, 1988). However, during ischemia, as well as after
brain injury or hemorrhage, the coupling between these neuronal
depolarization waves and CBF is inverted, such that the in-
creased neuronal activity is accompanied by a drop of CBF to
ischemic levels, indicating that this inverted neurovascular cou-
plingmay contribute to tissue damage (Dohmen et al., 2008; Dre-
ier et al., 2009; Petzold et al., 2003; Shin et al., 2006).
Functional hyperemia is also perturbed in Alzheimer’s disease
(Iadecola, 2004). In patients, resting CBF is reduced early in the
disease (Johnson and Albert, 2000), and functional hyperemia is
significantly impaired in animal models and patients (Hock et al.,
1996; Nicolakakis et al., 2008; Niwa et al., 2000b; Park et al.,
2004; Park et al., 2008; Shin et al., 2007; Smith et al., 1999;
Tong et al., 2005). Amyloid-b, the main constituent of amyloid
plaques in the brains of patients with Alzheimer’s disease, is
vasoactive in vitro (Crawford et al., 1998) and in vivo (Niwa
et al., 2000b), and soluble amyloid-b contributes to the reduction
of functional hyperemia in animal models in vivo (Niwa et al.,
2001b; Park et al., 2004), although it has also been suggested
that insoluble amyloid plaques and amyloid angiopathy are
necessary for this effect (Christie et al., 2001; Hu et al., 2008;
Shin et al., 2007). This perturbation of neurovascular coupling,
together with nonvascular mechanisms triggering neurodegen-
eration, may have synergistic detrimental effects on cognition
and memory in this disease (Iadecola, 2004).
Interestingly, dysregulation of astrocytic signaling has been
reported for all of these aforementioned diseases. Astrocytes
swell under ischemia, and because of their proximity to arterioles
and capillaries, this edema may contribute to the CBF reduction
in the microcirculation after stroke (Frydenlund et al., 2006; Man-
ley et al., 2000). On the other hand, astrocytes are also neuropro-
tective after ischemia and in other conditions (Barres, 2008;
Nedergaard and Dirnagl, 2005). Astrocytes also participate in
spreading neocortical depolarizations (Chuquet et al., 2007),
but to what extent they also contribute to the CBF response
and its inversion under pathological conditions remains un-
known. Finally, astrocytic calcium homeostasis is disrupted in
animal models of Alzheimer’s disease (Kuchibhotla et al., 2009),
but it remains to be determined whether these changes also
contribute to cerebrovascular dysregulation.
Concluding Remarks
There is substantial evidence now for the role of astrocytes
in neurovascular coupling. However, to establish with certainty
the exact aspects of functional hyperemia that astrocytes are
involved in, the following criteria must be satisfied: (1) astrocytes
must be activated in some way by neuronal signals that cause
functional hyperemia, (2) removing astrocytic signaling specifi-
cally in time and spatial location must perturb or abolish in-
creased blood flow caused by increased neural activity, and (3)
specifically activating astrocytic signals in the absence of neu-
ronal activity should lead to functional hyperemia. Of these, the792 Neuron 71, September 8, 2011 ª2011 Elsevier Inc.first requirement has significant experimental support, but the
last two have not been fully addressed. Significant progress
can be anticipated in the coming years in this field. We are partic-
ularly optimistic about the use of detailed cellular imaging and
cell biological manipulations in vivo. Application of cutting-
edge optical imaging methods, including multiphoton micros-
copy, has allowed a detailed dissection of different cellular
components—blood vessels, astrocytes, pericytes, endothe-
lium, and neurons. Since individual cells are elementary units
of tissue organization, probing their properties at high resolution
allows one to discern individual events that may be smoothed
out or buried within population signals. This sort of cell biology
in the intact brain will also be aided by unequivocal identification
of specific cell types using genetic methods. These novel ap-
proaches might be helpful for the interpretation of brain imaging
studies and to pinpoint the mechanisms involved in the dysregu-
lation of functional hyperemia in neurological diseases.
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